FREDERICK ALBANO: Open Payments
NPI 1548694011 · RIVERHEAD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 52 payments from 18 companies in 2025. Trend: 2023 $1,751 · 2024 $2,322 · 2025 $1,427
Food & beverage: $1,427
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $248 |
| Medtronic, Inc. | 8 | $149 |
| Ascendis Pharma Endocrinology Inc | 1 | $124 |
| Novo Nordisk Inc | 6 | $120 |
| ABBVIE INC. | 5 | $105 |
| CeQur Corporation | 1 | $101 |
| Xeris Pharmaceuticals, Inc. | 5 | $97 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $97 |
| Abbott Laboratories | 4 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $76 |
Products named: Dexcom G6 Transmitter, MINIMED 780G, Yorvipath, SYNTHROID, CeQur Simplicity, ISTURISA, FREESTYLE LIBRE 3, Kerendia.
Industry payments across NY — which companies pay providers there.
